ArticleOncotarget2016

A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer.

Luca Malorni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.